modified siRNAs (University of Barcelona/Universitat Autonoma de Barcelona/Fundació BOSCH I GIMPERA)

N/A

Report date: 2025/03/20 16:07:50
NME

Base Information

Drug Namemodified siRNAs (University of Barcelona/Universitat Autonoma de Barcelona/Fundació BOSCH I GIMPERA)
Drug Alias NameTNF-alpha gene expression inhibitors (University of Barcelona/Universitat Autonoma de Barcelona/Fundació BOSCH I GIMPERA)AVCRI 140
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTumor necrosis factor inhibitors
TargetsTumor necrosis factor
Therapy Area/IndicationsInflammationIrritable Bowel SyndromeNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversitat De Barcelona
China Registration ClassN/A

Develop Information

Active CompaniesUniversitat Autonoma De BarcelonaUniversitat De BarcelonaSpanish National Research Council
Inactive CompaniesN/A
Active IndicationsInflammationIrritable Bowel SyndromeNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A